Jack Lin

Stock Analyst at Morgan Stanley

(0.76)
# 4,113
Out of 4,698 analysts
29
Total ratings
40%
Success rate
-6%
Average return

Stocks Rated by Jack Lin

Abbisko Cayman Limited
Sep 4, 2026
Maintained: Buy
Price Target: $22.00
Current: $8.77
Upside: +151.00%
Akeso, Inc.
Aug 26, 2026
Maintained: Buy
Price Target: $215.00$212.00
Current: $101.20
Upside: +109.49%
Innovent Biologics, Inc.
Aug 25, 2026
Maintained: Buy
Price Target: $123.00$138.50
Current: $102.40
Upside: +35.25%
InnoCare Pharma Limited
Aug 25, 2026
Maintained: Buy
Price Target: $17.00
Current: $15.37
Upside: +10.61%
HUTCHMED (China)
May 28, 2026
Upgraded: Hold
Price Target: $14$14
Current: $14.09
Upside: -3.48%
HUTCHMED (China) Limited
May 28, 2026
Maintained: Hold
Price Target: $21.45$21.30
Current: $22.54
Upside: -5.50%
Duality Biotherapeutics, Inc.
Nov 20, 2025
Maintained: Buy
Price Target: $493.00
Current: $180.70
Upside: +172.83%
Zai Lab Limited
Nov 6, 2025
Maintained: Buy
Price Target: $37.50$37.44
Current: $20.76
Upside: +80.35%
RemeGen Co., Ltd.
Oct 30, 2025
Maintained: Hold
Price Target: $89.00
Current: $80.00
Upside: +11.25%
Everest Medicines Limited
Sep 22, 2025
Maintained: Hold
Price Target: $55.00
Current: $31.98
Upside: +71.98%
Maintained: Buy
Price Target: $93.50
Current: $79.75
Upside: +17.24%
Maintained: Buy
Price Target: $50$48
Current: $26.23
Upside: +83.00%